- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/18 - Antivirals for RNA viruses for HIV
Patent holdings for IPC class A61P 31/18
Total number of patents in this class: 4246
10-year publication summary
|
186
|
162
|
256
|
301
|
316
|
319
|
270
|
248
|
193
|
12
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 1951 |
234 |
| ViiV Healthcare UK (no.5) Limited | 89 |
77 |
| Duke University | 3011 |
71 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2838 |
65 |
| Bristol-myers Squibb Company | 4863 |
63 |
| ViiV Healthcare Company | 155 |
57 |
| Mondobiotech Laboratories AG | 311 |
56 |
| Centre National de La Recherche Scientifique | 10102 |
49 |
| Merck Sharp & Dohme LLC | 3751 |
49 |
| Merck Sharp & Dohme Corp. | 2219 |
43 |
| The Scripps Research Institute | 1353 |
35 |
| Shionogi & Co., Ltd. | 889 |
31 |
| F. Hoffmann-La Roche AG | 7942 |
30 |
| The Regents of the University of California | 19517 |
29 |
| Janssen Sciences Ireland Unlimited Company | 435 |
29 |
| Emory University | 1588 |
28 |
| Janssen Vaccines & Prevention B.V. | 334 |
28 |
| Cipla Limited | 469 |
27 |
| The Trustees of the University of Pennsylvania | 4260 |
25 |
| Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China | 188 |
23 |
| Other owners | 3197 |